From: The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
Group B vs. C
Group B vs. D
Group C vs. D
Temperature changes
0.009*
0.465
RSIs of BLI
0.834
0.047**
Apoptosis rates
0.675
0.028**
0.008*